about
Peptide Self-Assemblies for Drug Delivery.Artemisinins as potential anticancer agents: uptake detection in erythrocytes using Fourier transform infrared spectroscopy and cytotoxicity against bladder cancer cells.Carboxymethyl guar gum nanoparticles for drug delivery applications: Preparation and preliminary in-vitro investigations.Hollow-layered nanoparticles for therapeutic delivery of peptide prepared using electrospraying.Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation.Synthesis and characterization of N-(2-aminoethyl)-2-acetamidyl gellan gum with potential biomedical applications.Towards boron neutron capture therapy: the formulation and preliminary in vitro evaluation of liposomal vehicles for the therapeutic delivery of the dequalinium salt of bis-nido-carborane.Dual-stimuli-responsive hydrogels based on poly(N-isopropylacrylamide)/chitosan semi-interpenetrating networks.Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy.Hybrid polymeric hydrogels for ocular drug delivery: nanoparticulate systems from copolymers of acrylic acid-functionalized chitosan and N-isopropylacrylamide or 2-hydroxyethyl methacrylate.Vinylpyrrolidone-co-(meth)acrylic acid inserts for ocular drug delivery: synthesis and evaluation.Fluoropolymers as low-surface-energy tooth coatings for oral care.Towards carborane-functionalised structures for the treatment of brain cancer.Investigations of octylglyceryl dextran-graft-poly(lactic acid) nanoparticles for peptide delivery to the brain.Carbohydrate Nanoparticles for Brain Delivery.Functionalized chitosan/NIPAM (HEMA) hybrid polymer networks as inserts for ocular drug delivery: synthesis, in vitro assessment, and in vivo evaluation.Towards the Determination of Surface Energy at the Nanoscale: A Further Assessment of the AFM-Based ApproachMultifunctional poly(alkyl methacrylate) films for dental careOrally administered, colon-specific mucoadhesive azopolymer particles for the treatment of inflammatory bowel disease: Anin vivo studySustained Release from Injectable Composite Gels Loaded with Silver Nanowires Designed to Combat Bacterial Resistance in Bone Regeneration ApplicationsThe potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrierToward drug delivery into the brain: synthesis, characterization, and preliminary in vitro assessment of alkylglyceryl-functionalized chitosan nanoparticlesEngineering butylglyceryl-modified polysaccharides towards nanomedicines for brain drug deliveryEvaluation of Antibacterial and Cytotoxicity Properties of Silver Nanowires and Their Composites with Carbon Nanotubes for Biomedical ApplicationsButylglyceryl Pectin Nanoparticles: Synthesis, Formulation and CharacterizationPersonalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms
P50
Q38516043-9FD5BB0D-A7C1-4A21-9D75-413FADF6900CQ38772717-7D9E98C4-0D6F-49C0-A855-A7A3E21CEFF5Q38781127-F4E36E5E-85F5-49A1-BBE8-33F155CCD85EQ38829438-44641570-45BE-42B2-A2FB-99405595573FQ38873713-E160E1F1-DAFD-4399-ACDB-0AE8C4CE75F0Q39103466-630890A4-E405-48EB-838B-3A03ADF536A6Q43593023-D7B16D9C-42D9-440D-B500-9193BE02AB00Q44708602-4FD0CB88-80FA-479A-AF34-384929FC4504Q45876062-5C93CEDD-9B7E-4097-B28D-E03FEC354F58Q46015839-21D80D13-03FE-4625-9D9A-7B6C4849B681Q46602292-31E00AF1-9F5A-4A78-AA19-C20721352E87Q46863013-C62B3C83-4EF9-4B96-9851-B9055581A7A2Q48121633-30B77EA4-CF44-43B6-A4FC-718928E266DCQ48247082-B35E9D52-307A-4087-8445-81D31A2A177FQ48494105-206A9425-32F7-45B0-8AAC-FDDC5F6A3E89Q50735893-CB9EE16E-35D7-4237-83B5-956DC3452C54Q57765135-24F8D667-28EC-4AF9-A018-91EE8D56963DQ60511138-ABAAA43D-28CD-4B81-8D8E-0EFB47F7741FQ63341739-81AFD836-CDED-464D-A53A-C58563994E73Q64104951-67DD487A-973F-475A-861E-25E6838164C5Q83814322-6B0676DA-591D-4BA8-87B4-90B9732AC271Q85154220-64AAEDA5-0DC6-4172-96D8-8240FD664DBBQ90334000-5940D1ED-0300-476D-ADBC-0E1536C40399Q90737929-EC987C97-1186-48FC-AA0E-15F4C07C8577Q91742957-A4B9DF88-7D4C-4640-9EC2-ABDE9C70C76FQ91923828-2AEB0D60-5FD2-492B-8D9D-75A3EBB1168C
P50
description
researcher ORCID ID = 0000-0002-2053-4136
@en
name
Eugen Barbu
@ast
Eugen Barbu
@en
Eugen Barbu
@es
Eugen Barbu
@nl
type
label
Eugen Barbu
@ast
Eugen Barbu
@en
Eugen Barbu
@es
Eugen Barbu
@nl
prefLabel
Eugen Barbu
@ast
Eugen Barbu
@en
Eugen Barbu
@es
Eugen Barbu
@nl
P31
P496
0000-0002-2053-4136